All Stories

  1. Tear Cytokines as Predictive Biomarkers of Success in Contact Lens Discomfort Management
  2. Analysis of the mucosal chemokines CCL28, CXCL14, and CXCL17 in dry eye disease: An in vitro and clinical investigation
  3. Short-Term Efficacy of Ophthalmic Cyclosporine: A 0.1% Cationic Emulsion in Dry Eye Patients Assessed Under Controlled Environment
  4. Influence of controlled environmental conditions in potential salivary ocular pain biomarkers for enhancing the assessment of ocular pain
  5. Gene expression changes in conjunctival cells associated with contact lens wear and discomfort
  6. Diurnal variation on tear stability and correlation with tear cytokine concentration
  7. Tear and Plasma Levels of Cytokines in Patients with Uveitis: Search for Active Disease Biomarkers
  8. Effect of a single vectored thermal pulsation treatment of Meibomian gland dysfunction patients under controlled environmental conditions
  9. Olive Pomace Phenolic Compounds: From an Agro-Industrial By-Product to a Promising Ocular Surface Protection for Dry Eye Disease
  10. Special Issue on “Potential Biomarkers in Tears”
  11. Conjunctival Intraepithelial Lymphocytes, Lacrimal Cytokines and Ocular Commensal Microbiota: Analysis of the Three Main Players in Allergic Conjunctivitis
  12. Inflammation-related molecules in tears of patients with chronic ocular pain and dry eye disease
  13. Potential Ophthalmological Application of Extracts Obtained from Tuna Vitreous Humor Using Lactic Acid-Based Deep Eutectic Systems
  14. Olive Pomace Phenolic Compounds Stability and Safety Evaluation: From Raw Material to Future Ophthalmic Applications
  15. Age- and Sex-Adjusted Reference Intervals in Tear Cytokine Levels in Healthy Subjects
  16. Ocular Surface Pathology in Patients Suffering from Mercury Intoxication
  17. Olive Pomace Phenolic Compounds and Extracts Can Inhibit Inflammatory- and Oxidative-Related Diseases of Human Ocular Surface Epithelium
  18. A Pilot Proteomic Study of Normal Human Tears: Leptin as a Potential Biomarker of Metabolic Disorders
  19. Pressurized Liquid Extraction Optimization from Supercritical Defatted Olive Pomace: A Green and Selective Phenolic Extraction Process
  20. Ocular Surface Pathology in Patients Suffering From Mercury Intoxication Is Consistent With Neurogenic Dry Eye Disease
  21. Inflammatory status predicts contact lens discomfort under adverse environmental conditions
  22. Clinical and tear cytokine profiles after advanced surface ablation refractive surgery: A six-month follow-up
  23. Tear Inflammatory Molecules in Contact Lens Wearers: A Literature Review
  24. Development of a Questionnaire for Detecting Changes in Dry Eye Disease–Related Symptoms
  25. Conjunctival Neuropathic and Inflammatory Pain-Related Gene Expression with Contact Lens Wear and Discomfort
  26. Is there any difference in the ocular surface between subjects with and without contact lens discomfort?
  27. Substance P Level in Tears as a Potential Biomarker for Contact Lens Discomfort
  28. Response profiles to a controlled adverse desiccating environment based on clinical and tear molecule changes
  29. The ability of the Contact Lens Dry Eye Questionnaire (CLDEQ)-8 to detect ocular surface alterations in contact lens wearers
  30. Topical Quercetin and Resveratrol Protect the Ocular Surface in Experimental Dry Eye Disease
  31. Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial
  32. Effect of the environmental conditions on tear inflammatory mediators concentration in contact lens wearers
  33. Topical fluorometholone treatment and desiccating stress change inflammatory protein expression in tears
  34. Are Contact Lens Discomfort or Soft Contact Lens Material Properties Associated with Alterations in the Corneal Sub-Basal Nerve Plexus?
  35. Prehematopoietic Stem Cell Transplantation Tear Cytokines as Potential Susceptibility Biomarkers for Ocular Chronic Graft-Versus-Host Disease
  36. Reply
  37. RNA Collection From Human Conjunctival Epithelial Cells Obtained With a New Device for Impression Cytology
  38. Effects of the External Environment on Dry Eye Disease
  39. Cytokine and chemokine tear levels in patients with uveitis
  40. Effect of Environmental Conditions on the Concentration of Tear Inflammatory Mediators During Contact Lens Wear
  41. Corneal Sensitivity and Inflammatory Biomarkers in Contact Lens Discomfort
  42. Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine
  43. Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model
  44. Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress
  45. Clinical and Molecular Inflammatory Response in Sjögren Syndrome–Associated Dry Eye Patients Under Desiccating Stress
  46. Gene Expression–Based Predictive Models of Graft Versus Host Disease–Associated Dry Eye
  47. Quercetin and Resveratrol Decrease the Inflammatory and Oxidative Responses in Human Ocular Surface Epithelial Cells
  48. In VitroModel for Predicting the Protective Effect of Ultraviolet-Blocking Contact Lens in Human Corneal Epithelial Cells
  49. Dry Eye Exacerbation in Patients Exposed to Desiccating Stress under Controlled Environmental Conditions
  50. Intra- and inter-day variation of cytokines and chemokines in tears of healthy subjects
  51. Basal values, intra-day and inter-day variations in tear film osmolarity and tear fluorescein clearance
  52. Influence of a Controlled Environment Simulating an In-Flight Airplane Cabin on Dry Eye Disease
  53. Effect of TGF-β on ocular surface epithelial cells
  54. Molecular and cellular biomarkers in dry eye disease and ocular allergy
  55. Activation of MAPK Signaling Pathway and NF-κB Activation in Pterygium and Ipsilateral Pterygium-Free Conjunctival Specimens
  56. Cytokine and chemokine levels in tears from healthy subjects
  57. Dry Eye Disease as an Inflammatory Disorder
  58. Iris Abscess as an Unusual Presentation of Endogenous Endophthalmitis after Intramuscular Injection
  59. Cytokine responses by conjunctival epithelial cells: An in vitro model of ocular inflammation
  60. Cytokines and chemokines in immune-based ocular surface inflammation
  61. Muscarinic receptors in the ocular surface
  62. Altered Expression of Neurotransmitter Receptors and Neuromediators in Vernal Keratoconjunctivitis
  63. Chitosan Nanoparticles as a Potential Drug Delivery System for the Ocular Surface: Toxicity, Uptake Mechanism and In Vivo Tolerance
  64. The role of the conjunctival epithelium in ocular allergy
  65. Variation in the Expression of Inflammatory Markers and Neuroreceptors in Human Conjunctival Epithelial Cells
  66. Response of rat fasciculata-reticularis cells in primary culture to bacterial lipopolysaccharide
  67. Expression of Muscarinic and Adrenergic Receptors in Normal Human Conjunctival Epithelium
  68. α2-Adrenergic Receptors Are Present in Normal Human Conjunctiva
  69. Expression of Neurotransmitter Receptors in Normal and Inflamed Human Conjunctival Epithelium
  70. Nanotechnologies for Ocular Surface Disorder Management: A Promising Approach
  71. Conjunctival Epithelium Biology: Role of Conjunctival Epithelial Cells In Vitro
  72. Impression cytology of the ocular surface: a review
  73. Characterization of a Spontaneously Immortalized Cell Line (IOBA-NHC) from Normal Human Conjunctiva
  74. Rat glomerulosa cells in primary culture and E. coli lipopolysaccharide action
  75. Binding ofEscherichia coli lipopolysaccharide to fasciculata-reticularis and glomerulosa cells evaluated by flow cytometry
  76. Calcium and reactive oxygen species as messengers in endotoxin action on adrenocortical cells